Autoimmunity to ECGF in Lyme disease and its post-infectious syndromes

莱姆病及其感染后综合征中 ECGF 的自身免疫

基本信息

  • 批准号:
    8543853
  • 负责人:
  • 金额:
    $ 60.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-24 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Certain manifestations of Lyme disease (LD) do not resolve with antibiotic therapy. We have studied this problem previously in patients with Lyme arthritis who have persistent synovitis for months or years after spirochetal killing with antibiotics, called antibiotic-refractory Lyme arthritis. We have hypothesized that this disease course results from infection-induced autoimmunity with immune dysregulation in joints. However, until recently, identification of pathogenic autoantigens has remained elusive. Using discovery-based proteomics combined with clinical translational research, we recently identified endothelial cell growth factor (ECGF) as the first known autoantigen that induces T and B cell responses in patients with antibiotic- refractory Lyme arthritis. Our first specific aim in this application is to determine the clinical correlates of autoimmunity across the spectrum of LD, including erythema migrans, neuroborreliosis, carditis, arthritis, and post-infectious syndromes, to assess whether this response is specific for LD, and to learn whether it occurs only with U.S. B. burgdorferi (Bb) strains or also with European genospecies of the spirochete. Second, we want to understand spirochetal and host cell interactions, including the types of Bb strains and host cell types, which are necessary for the induction of ECGF and ECGF immune responses. Third, we plan to characterize the phenotype, function and gene expression of immune cell subsets that lead to immune dysregulation in joints in patients with antibiotic-refractory arthriti, and to learn whether such abnormalities occur in patients with other LD pictures. These aims will allow us to expand our observation that autoimmunity to ECGF can occur as a part of the spectrum of Bb-induced immune responses, to ascertain whether specific clinical pictures result from such immune responses, to delineate mechanisms that account for these responses, and to characterize features of immune dysregulation that lead to persistent disease activity. If these studies validate ECGF as a pathogenic autoantigen, we anticipate that a test for this antibody response will become a part of the clinical evaluation of LD. Finally, this work has implications beyond LD, since it may create a new paradigm for how to identify and understand infection-induced autoimmunity with immune dysregulation in other diseases.
描述(由申请人提供):莱姆病(LD)的某些症状不能通过抗生素治疗解决。我们以前曾在莱姆关节炎患者中研究过这个问题,这些患者在用抗生素杀死螺旋体后持续滑膜炎数月或数年,称为抗生素难治性莱姆关节炎。我们假设这种疾病的病程是由感染诱导的自身免疫和关节的免疫失调所致。然而,直到最近,对致病自身抗原的鉴定仍然难以捉摸。利用基于发现的蛋白质组学和临床翻译研究相结合的方法,我们最近发现内皮细胞生长因子(ECGF)是第一个已知的诱导抗生素难治性莱姆关节炎患者T和B细胞反应的自身抗原。我们在这项应用中的第一个具体目标是确定各种LD的自身免疫的临床相关性,包括红斑迁徙、神经疏螺旋体病、心脏炎、关节炎和感染后综合征,评估这种反应是否是LD特有的,并了解它是仅发生在美国伯氏杆菌(BB)菌株还是也发生在欧洲的螺旋体基因种。其次,我们想了解螺旋体和宿主细胞的相互作用,包括BB菌株的类型和宿主细胞类型,这是诱导ECGF和ECGF免疫反应所必需的。第三,我们计划表征导致抗生素难治性关节炎患者关节免疫失调的免疫细胞亚群的表型、功能和基因表达,并了解这种异常是否发生在其他LD照片的患者中。这些目的将使我们能够扩大我们的观察,即对ECGF的自身免疫可以作为BB诱导的免疫反应的一部分来发生,以确定这种免疫反应是否产生特定的临床表现,描述解释这些反应的机制,并表征导致持续疾病活动的免疫失调的特征。如果这些 研究证实ECGF是一种致病的自身抗原,我们预计这种抗体反应的检测将成为LD临床评估的一部分。最后,这项工作具有超越LD的意义,因为它可能为如何识别和理解感染诱导的自身免疫以及其他疾病中的免疫失调创造了一个新的范式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALLEN C STEERE其他文献

ALLEN C STEERE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALLEN C STEERE', 18)}}的其他基金

Cellular and humoral immunity in Lyme arthritis
莱姆关节炎的细胞和体液免疫
  • 批准号:
    10317057
  • 财政年份:
    2019
  • 资助金额:
    $ 60.08万
  • 项目类别:
Cellular and humoral immunity in Lyme arthritis
莱姆关节炎的细胞和体液免疫
  • 批准号:
    10541106
  • 财政年份:
    2019
  • 资助金额:
    $ 60.08万
  • 项目类别:
Autoimmunity to ECGF in Lyme disease and its post-infectious syndromes
莱姆病及其感染后综合征中 ECGF 的自身免疫
  • 批准号:
    8501754
  • 财政年份:
    2013
  • 资助金额:
    $ 60.08万
  • 项目类别:
Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease
伯氏疏螺旋体诱导的莱姆病自身免疫
  • 批准号:
    9757687
  • 财政年份:
    2013
  • 资助金额:
    $ 60.08万
  • 项目类别:
Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease
伯氏疏螺旋体诱导的莱姆病自身免疫
  • 批准号:
    10215511
  • 财政年份:
    2013
  • 资助金额:
    $ 60.08万
  • 项目类别:
Autoimmunity to ECGF in Lyme disease and its post-infectious syndromes
莱姆病及其感染后综合征中 ECGF 的自身免疫
  • 批准号:
    9067207
  • 财政年份:
    2013
  • 资助金额:
    $ 60.08万
  • 项目类别:
Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease
伯氏疏螺旋体诱导的莱姆病自身免疫
  • 批准号:
    9980768
  • 财政年份:
    2013
  • 资助金额:
    $ 60.08万
  • 项目类别:
Autoimmunity to ECGF in Lyme disease and its post-infectious syndromes
莱姆病及其感染后综合征中 ECGF 的自身免疫
  • 批准号:
    8667985
  • 财政年份:
    2013
  • 资助金额:
    $ 60.08万
  • 项目类别:
IMMUNE RESPONSE TO B BURGDORFERI PROTEINS IN LYME ARTHRITIS
莱姆关节炎中对布氏 B 蛋白的免疫反应
  • 批准号:
    8365544
  • 财政年份:
    2011
  • 资助金额:
    $ 60.08万
  • 项目类别:
IMMUNE RESPONSE TO B BURGDORFERI PROTEINS IN LYME ARTHRITIS
莱姆关节炎中对布氏 B 蛋白的免疫反应
  • 批准号:
    8170913
  • 财政年份:
    2010
  • 资助金额:
    $ 60.08万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了